Green Tea Extract
Dietary Supplement500 mg . one capsule of green tea extract, 3 times per day
Other names: EGCG: Green tea extract
NCT Number: NCT01360567
The aim of the study is to examine whether the extract of green tea is effective on type 2 diabetes and hyperlipidemia.
Looking for future studies?
Notify Me20 year–60 year
All sexes
Interventional
Phase 3
Chung-Hua Hsu, Taipei, Taiwan
Percent change Homa insulin resistance, cholesterol and triglycerol.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
500 mg . one capsule of green tea extract, 3 times per day
Other names: EGCG: Green tea extract
500 mg . one capsule of placebo, 3 times per day
Time frame: 16 weeks
Time frame: 16 weeks
Taipei City Hospital
Other Gov
Taipei City Hospital, Taipei, Taiwan
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02437084
Diabetes Mellitus, Diabetes Mellitus, Type 2
Stanford, California, United States
View Trial DetailsNCT01607294
Diabetes Mellitus, Diabetes Mellitus, Type 2
Miramar, Florida, United States
View Trial DetailsNCT01145742
Cardiovascular Diseases, Diabetes Mellitus
The Bronx, New York, United States
View Trial DetailsNCT00484419
Diabetes Mellitus, Diabetes Mellitus, Type 2
La Mesa, California, United States
View Trial Details